Skip to content

PhD in Pharmacy and Pharmaceutical Sciences: Discovery of novel cancer immunotherapeutic agents

Although cancer therapeutics, mainly chemotherapy and radiotherapy, have been extremely useful in the treatment of cancer, this disease is still associated with high morbidity and mortality.

With the aim of discovering new treatments for cancer, in this PhD project, the design, synthesis and biological evaluation of small synthetic molecules that manipulate the immune system to eliminate cancer cells will be pursued. This project will benefit from some immunotherapeutic small molecules that we recently discovered and which will form the basis for the work of the PhD project.

From working on this project, the student will learn the synthesis, purification and characterisation of small molecules, drug design and development as well as assay development for testing the biological activities of synthetic molecules. Such knowledge will be extremely valuable for those wishing to pursue a career in academia or with pharmaceutical/biotechnology companies.

Apply

Applications are accepted all year round for this self-funded PhD and interested candidates should contact Dr. Youcef Mehellou.

Supervisors

Dr Youcef Mehellou

Dr Youcef Mehellou

Senior Lecturer

Email:
mehellouy1@cardiff.ac.uk
Telephone:
+44 (0)29 2087 5821

Programme information

For programme structure, entry requirements and how to apply, visit the Pharmacy and Pharmaceutical Sciences programme.

View programme
Join us from 10:00 - 15:00 on Wednesday 4 December to find out more about postgraduate study at Cardiff University.

Related programmes

Related links